Avanir
A Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess theefficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide[d6-DM]/quinidine sulfate [Q]) for the treatment of agitation in patients with dementia ofthe Alzheimer’s type
A Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess theefficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide[d6-DM]/quinidine sulfate [Q]) for the treatment of agitation in patients with dementia ofthe Alzheimer’s type
